Polyoma virus assembly occurs by sequential addition of capsid proteins to the viral minichromosome to form a complete T=7d icosahedral virion.
The specific aims of this proposal address two questions concerning the assembly pathway: 1) how are the individual capsid proteins localized to the site of virus assembly, and 2) are there specific DNA binding sites for the initiation of virion encapsidation? Large amounts of the individual polyoma capsid proteins will be produced by molecular cloning in E. coli. Capsid proteins purified from E. coli will then be used to study their in vitro binding to DNA and to generate affinity purified antibodies. The intracellular localization of these proteins will be studied using immunofluorescence of individual capsid protein genes transfected into NIH 3T3 cells. Encapsidation initiation sequences will be assayed by adding polyoma DNA sequences to episomal bovine papilloma virus (BPV), introducing the modified BPV genome into C127 mouse cells, and determining whether the BPV minichromosome subsequently can be encapsidated during a lytic polyoma infection. Because the polyoma life cylce must interface with normal cellular processes, we anticipate that polyoma assembly will have significance to basic eukaryotic biological processes including the subcellular localization of proteins, chromatin structure, gene regulation, and other macromolecular assembly mechanisms. In the long term, a more complete understanding of the viral life cycle will be relevant to designing and understanding anti-viral chemotherapy, and to elucidating the role of polyoma's transforming genes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037667-02
Application #
3175461
Study Section
Virology Study Section (VR)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
Heiser, Katie; Nicholas, Catherine; Garcea, Robert L (2016) Activation of DNA damage repair pathways by murine polyomavirus. Virology 497:346-356
O'Hara, Samantha D; Garcea, Robert L (2016) Murine Polyomavirus Cell Surface Receptors Activate Distinct Signaling Pathways Required for Infection. MBio 7:
Buch, Michael H C; Liaci, A Manuel; O'Hara, Samantha D et al. (2015) Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity. PLoS Pathog 11:e1005104
Berrios, Christian; Jung, Joonil; Primi, Blake et al. (2015) Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J Virol 89:857-62
You, John; O'Hara, Samantha D; Velupillai, Palanivel et al. (2015) Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus. PLoS Pathog 11:e1005175
Lim, Efrem S; Meinerz, Natalie M; Primi, Blake et al. (2014) Common exposure to STL polyomavirus during childhood. Emerg Infect Dis 20:1559-61
Ströh, Luisa J; Neu, Ursula; Blaum, Bärbel S et al. (2014) Structure analysis of the major capsid proteins of human polyomaviruses 6 and 7 reveals an obstructed sialic acid binding site. J Virol 88:10831-9
DeCaprio, James A; Garcea, Robert L (2013) A cornucopia of human polyomaviruses. Nat Rev Microbiol 11:264-76
Erickson, Kimberly D; Bouchet-Marquis, Cedric; Heiser, Katie et al. (2012) Virion assembly factories in the nucleus of polyomavirus-infected cells. PLoS Pathog 8:e1002630
Bienkowska-Haba, Malgorzata; Williams, Carlyn; Kim, Seong Man et al. (2012) Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol 86:9875-87

Showing the most recent 10 out of 55 publications